Search research articles
Contact Us
Filters
Showing results (81-90 of 191) with videos related to
Page
of 20
Sort By:
Annals of Hematology
|
July 20, 2020
Drug-drug interactions of newly approved small molecule inhibitors for acute myeloid leukemia
Juan Eduardo Megías-Vericat, Antonio Solana-Altabella, Octavio Ballesta-López, et al.
Expert Review of Clinical Pharmacology
|
January 24, 2019
Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review
Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Miguel Ángel Sanz, et al.
British Journal of Pharmacology
|
December 1, 1991
Effects of PAF-antagonists in mouse ear oedema induced by several inflammatory agents
M Merlos, L A Gómez, M Giral, et al.
The Science of the Total Environment
|
July 20, 2015
Effects of afforestation on runoff and sediment load in an upland Mediterranean catchment
C Buendia, G Bussi, J Tuset, et al.
Pharmaceutics
|
April 23, 2022
Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia
Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Antonio Solana-Altabella, et al.
Expert Opinion on Emerging Drugs
|
January 25, 2022
Emerging FLT3 inhibitors for the treatment of acute myeloid leukemia
Antonio Solana-Altabella, Octavio Ballesta-López, Juan Eduardo Megías-Vericat, et al.
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry
|
January 10, 2017
The Role of a Double Molecular Anchor on the Mobility and Self-Assembly of Thiols on Au(111): The Case of Mercaptobenzoic Acid
Miriam C Rodríguez González, Pilar Carro, Evangelina Pensa, et al.
Future Oncology (London, England)
|
September 25, 2020
Gilteritinib use in the treatment of relapsed or refractory acute myeloid leukemia with a <i>FLT3</i> mutation
Octavio Ballesta-López, Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria
|
April 5, 2022
Monitoring coagulation factors during surgery. A systematic review
Juan Eduardo Megías-Vericat, Santiago Bonanad-Boix, María Remedios Marqués-Miñana, et al.
Expert Review of Clinical Pharmacology
|
January 28, 2023
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape
Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, et al.
Page
of 20
Search research articles
Search
Showing results (81-90 of 191) with videos related to
Sort By:
Page
of 20
Annals of Hematology
|
July 20, 2020
Drug-drug interactions of newly approved small molecule inhibitors for acute myeloid leukemia
Juan Eduardo Megías-Vericat, Antonio Solana-Altabella, Octavio Ballesta-López, et al.
Expert Review of Clinical Pharmacology
|
January 24, 2019
Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review
Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Miguel Ángel Sanz, et al.
British Journal of Pharmacology
|
December 1, 1991
Effects of PAF-antagonists in mouse ear oedema induced by several inflammatory agents
M Merlos, L A Gómez, M Giral, et al.
The Science of the Total Environment
|
July 20, 2015
Effects of afforestation on runoff and sediment load in an upland Mediterranean catchment
C Buendia, G Bussi, J Tuset, et al.
Pharmaceutics
|
April 23, 2022
Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia
Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Antonio Solana-Altabella, et al.
Expert Opinion on Emerging Drugs
|
January 25, 2022
Emerging FLT3 inhibitors for the treatment of acute myeloid leukemia
Antonio Solana-Altabella, Octavio Ballesta-López, Juan Eduardo Megías-Vericat, et al.
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry
|
January 10, 2017
The Role of a Double Molecular Anchor on the Mobility and Self-Assembly of Thiols on Au(111): The Case of Mercaptobenzoic Acid
Miriam C Rodríguez González, Pilar Carro, Evangelina Pensa, et al.
Future Oncology (London, England)
|
September 25, 2020
Gilteritinib use in the treatment of relapsed or refractory acute myeloid leukemia with a <i>FLT3</i> mutation
Octavio Ballesta-López, Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria
|
April 5, 2022
Monitoring coagulation factors during surgery. A systematic review
Juan Eduardo Megías-Vericat, Santiago Bonanad-Boix, María Remedios Marqués-Miñana, et al.
Expert Review of Clinical Pharmacology
|
January 28, 2023
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape
Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, et al.
Page
of 20